|
JP4253126B2
(ja)
|
1998-01-29 |
2009-04-08 |
アムジェン インコーポレイテッド |
Ｐｐａｒ−ガンマ調節剤
|
|
US20080269265A1
(en)
|
1998-12-22 |
2008-10-30 |
Scott Miller |
Inhibition Of Raf Kinase Using Symmetrical And Unsymmetrical Substituted Diphenyl Ureas
|
|
SI1478358T1
(sl)
|
2002-02-11 |
2013-09-30 |
Bayer Healthcare Llc |
Sorafenib tozilat za zdravljenje bolezni, značilnih po abnormalni angiogenezi
|
|
AR041191A1
(es)
|
2002-08-08 |
2005-05-04 |
Amgen Inc |
Ligandos del receptor vanilloide y su uso en tratamientos
|
|
EA013811B1
(ru)
|
2002-11-21 |
2010-08-30 |
Новартис Вэксинес Энд Дайэгностикс, Инк. |
2,4,6-тризамещённые пиримидины, являющиеся ингибиторами фосфотидилинозитол(pi)-3-киназы, и их применение при лечении рака
|
|
US7202257B2
(en)
|
2003-12-24 |
2007-04-10 |
Deciphera Pharmaceuticals, Llc |
Anti-inflammatory medicaments
|
|
US7144911B2
(en)
|
2002-12-31 |
2006-12-05 |
Deciphera Pharmaceuticals Llc |
Anti-inflammatory medicaments
|
|
US7279576B2
(en)
|
2002-12-31 |
2007-10-09 |
Deciphera Pharmaceuticals, Llc |
Anti-cancer medicaments
|
|
US20050014753A1
(en)
|
2003-04-04 |
2005-01-20 |
Irm Llc |
Novel compounds and compositions as protein kinase inhibitors
|
|
US7504401B2
(en)
|
2003-08-29 |
2009-03-17 |
Locus Pharmaceuticals, Inc. |
Anti-cancer agents and uses thereof
|
|
KR101195801B1
(ko)
|
2004-06-18 |
2012-11-05 |
밀레니엄 파머슈티컬스 인코퍼레이티드 |
Ｘａ 인자 억제제
|
|
GB0415364D0
(en)
|
2004-07-09 |
2004-08-11 |
Astrazeneca Ab |
Pyrimidine derivatives
|
|
AU2005284904A1
(en)
|
2004-09-13 |
2006-03-23 |
Amgen Inc. |
Vanilloid receptor ligands and their use in treatments
|
|
US20090018145A1
(en)
|
2004-10-19 |
2009-01-15 |
Compass Pharmaceuticals Llc |
Compositions and their use as anti-tumor agents
|
|
WO2006049941A2
(en)
|
2004-10-27 |
2006-05-11 |
Neurogen Corporation |
Diaryl ureas as cb1 antagonists
|
|
CA2592118C
(en)
|
2004-12-23 |
2015-11-17 |
Deciphera Pharmaceuticals, Llc |
Urea derivatives as enzyme modulators
|
|
ES2382068T3
(es)
|
2004-12-28 |
2012-06-05 |
Kinex Pharmaceuticals, Llc |
Composiciones y métodos para tratar trastornos de proliferación celular
|
|
US20060178388A1
(en)
|
2005-02-04 |
2006-08-10 |
Wrobleski Stephen T |
Phenyl-substituted pyrimidine compounds useful as kinase inhibitors
|
|
TW200716594A
(en)
|
2005-04-18 |
2007-05-01 |
Neurogen Corp |
Substituted heteroaryl CB1 antagonists
|
|
US7897762B2
(en)
|
2006-09-14 |
2011-03-01 |
Deciphera Pharmaceuticals, Llc |
Kinase inhibitors useful for the treatment of proliferative diseases
|
|
US8188113B2
(en)
|
2006-09-14 |
2012-05-29 |
Deciphera Pharmaceuticals, Inc. |
Dihydropyridopyrimidinyl, dihydronaphthyidinyl and related compounds useful as kinase inhibitors for the treatment of proliferative diseases
|
|
US7790756B2
(en)
|
2006-10-11 |
2010-09-07 |
Deciphera Pharmaceuticals, Llc |
Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases
|
|
GB0625659D0
(en)
|
2006-12-21 |
2007-01-31 |
Cancer Rec Tech Ltd |
Therapeutic compounds and their use
|
|
WO2008131276A1
(en)
|
2007-04-20 |
2008-10-30 |
Deciphera Pharmaceuticals, Llc |
Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases
|
|
US8343966B2
(en)
|
2008-01-11 |
2013-01-01 |
Novartis Ag |
Organic compounds
|
|
JP2011522865A
(ja)
|
2008-06-13 |
2011-08-04 |
ノバルティス アーゲー |
Ｉａ心不全および癌の治療に有用なプロテインキナーゼｄ阻害剤としての２，４’−ビピリジニル化合物
|
|
JP5444365B2
(ja)
|
2008-10-29 |
2014-03-19 |
デシフェラ ファーマシューティカルズ，エルエルシー |
抗癌活性および抗増殖活性を示すシクロプロパンアミドおよび類似物質
|
|
EP2542536B1
(en)
|
2010-03-04 |
2015-01-21 |
Cellzome Limited |
Morpholino substituted urea derivatives as mtor inhibitors
|
|
CA2800998A1
(en)
|
2010-04-29 |
2011-11-10 |
Deciphera Pharmaceuticals, Llc |
Pyridone amides and analogs exhibiting anti-cancer and anti-proliferative activities
|
|
SG185073A1
(en)
|
2010-04-29 |
2012-12-28 |
Deciphera Pharmaceuticals Llc |
Cyclopropyl dicarboxamides and analogs exhibiting anti-cancer and anti-proliferative activites
|
|
JP2015507606A
(ja)
|
2011-11-22 |
2015-03-12 |
デシフェラ ファーマシューティカルズ，エルエルシー |
抗癌および抗増殖作用を示すピリドンアミドおよび類似体
|
|
AR090151A1
(es)
|
2012-03-07 |
2014-10-22 |
Lilly Co Eli |
Compuestos inhibidores de raf
|
|
WO2013134298A1
(en)
|
2012-03-07 |
2013-09-12 |
Deciphera Pharmaceuticals, Llc |
Raf inhibitor compounds
|
|
US8461179B1
(en)
|
2012-06-07 |
2013-06-11 |
Deciphera Pharmaceuticals, Llc |
Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases
|
|
US9242969B2
(en)
*
|
2013-03-14 |
2016-01-26 |
Novartis Ag |
Biaryl amide compounds as kinase inhibitors
|
|
WO2014145023A1
(en)
|
2013-03-15 |
2014-09-18 |
Deciphera Pharmaceuticals, Llc |
1,2,4-triazol-5-ones and analogs exhibiting anti-cancer and anti-proliferative activities
|
|
US9012635B2
(en)
|
2013-03-15 |
2015-04-21 |
Deciphera Pharmaceuticals, Llc |
Pyridone amides and analogs exhibiting anti-cancer and anti-proliferative activities
|
|
WO2014145015A2
(en)
|
2013-03-15 |
2014-09-18 |
Deciphera Pharmaceuticals, Llc |
Imidazolidinones and analogs exhibiting anti-cancer and anti-proliferative activities
|
|
WO2014145029A2
(en)
|
2013-03-15 |
2014-09-18 |
Deciphera Pharmaceuticals, Llc |
N-acyl-n'-(pyridin-2-yl) ureas and analogs exhibiting anti-cancer and anti-proliferative activities
|
|
DK2968286T3
(en)
|
2013-03-15 |
2018-01-02 |
Deciphera Pharmaceuticals Llc |
2-AMINOPYRIMIDIN-6-ONES AND ANALOGS THAT HAVE ANTI-CANCER AND ANTI-PROLIFERATIVE ACTIVITIES
|
|
JP6364472B2
(ja)
|
2013-03-15 |
2018-07-25 |
デシフェラ ファーマシューティカルズ，エルエルシー |
抗がんおよび抗増殖活性を示すｎ−アシル−ｎ’−（ピリジン−２−イル）尿素および類似体
|
|
US9758492B2
(en)
|
2013-08-27 |
2017-09-12 |
Bristol-Myers Squibb Company |
IDO inhibitors
|
|
BR112016008632A8
(pt)
|
2013-10-21 |
2020-03-17 |
Merck Patent Gmbh |
compostos de heteroarila como inibidores de btk, seus usos, e composição farmacêutica
|
|
WO2015059618A1
(en)
|
2013-10-22 |
2015-04-30 |
Glenmark Pharmaceuticals S.A. |
SUBSTITUTED PYRIMIDINE COMPOUNDS AS mPGES-1 INHIBITORS
|
|
US9457019B2
(en)
|
2013-11-07 |
2016-10-04 |
Deciphera Pharmaceuticals, Llc |
Methods for inhibiting tie-2 kinase useful in the treatment of cancer
|
|
CA2935683A1
(en)
|
2013-12-30 |
2015-07-09 |
Lifesci Pharmaceuticals, Inc. |
Therapeutic inhibitory compounds
|
|
WO2015108861A1
(en)
|
2014-01-14 |
2015-07-23 |
Millennium Pharmaceuticals, Inc. |
Heteroaryls and uses thereof
|
|
CN107074828B
(zh)
|
2014-09-12 |
2020-05-19 |
诺华股份有限公司 |
用作raf激酶抑制剂的化合物和组合物
|
|
WO2018104307A1
(en)
|
2016-12-09 |
2018-06-14 |
Bayer Pharma Aktiengesellschaft |
Aromatic sulfonamide derivatives and their use as anatagon i sts or negative allosteric modulators of p2x4
|
|
MY205552A
(en)
|
2017-05-30 |
2024-10-25 |
Deciphera Pharmaceuticals Inc |
Use of 1-[4-bromo-5-[1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl]-2-fluorophenyl ]-3-phenylurea and analogs for the treatment of cancers associated with genetic abnormalities in platelet derived growth factor receptor alpha
|
|
EP3746070A4
(en)
|
2018-01-29 |
2021-09-01 |
Capulus Therapeutics, LLC |
SREBP INHIBITORS WITH A 6-LINKED CENTER RING
|
|
CN118416236A
(zh)
|
2018-01-31 |
2024-08-02 |
德西费拉制药有限责任公司 |
治疗胃肠道间质瘤的组合疗法
|
|
IL276398B2
(en)
|
2018-01-31 |
2026-03-01 |
Deciphera Pharmaceuticals Llc |
Combination therapy for mastocytosis
|
|
KR102803762B1
(ko)
|
2018-04-10 |
2025-05-09 |
뉴로포레 테라피스, 인코포레이티드 |
Pi3-키나제 및 오토파지 경로의 조절인자로서의 트리-치환된 아릴 및 헤테로아릴 유도체
|
|
US11945803B2
(en)
|
2018-08-07 |
2024-04-02 |
Tosk, Inc. |
Modulators of RAS GTPase
|
|
BR112021012812A2
(pt)
|
2018-12-28 |
2021-12-07 |
Deciphera Pharmaceuticals Llc |
Csf1r inhibitors para uso e tratamento de câncer
|
|
WO2020198058A1
(en)
|
2019-03-22 |
2020-10-01 |
Kinnate Biopharma Inc. |
Inhibitors of raf kinases
|
|
US11518758B2
(en)
|
2019-05-10 |
2022-12-06 |
Deciphera Pharmaceuticals, Llc |
Heteroarylaminopyrimidine amide autophagy inhibitors and methods of use thereof
|
|
PE20220597A1
(es)
|
2019-05-10 |
2022-04-22 |
Deciphera Pharmaceuticals Llc |
Inhibidores de la autofagia de fenilaminopirimidina amida y metodos de uso de estos
|
|
EP3969449B1
(en)
*
|
2019-05-13 |
2025-02-12 |
Novartis AG |
New crystalline forms of n-(3-(2-(2-hydroxyethoxy)-6-morpholinopyridin-4-yl)-4-methvlphenyl)-2(trifluoromethyl)isonicotinamide as raf inhibitors for the treatment of cancer
|
|
WO2020232256A1
(en)
|
2019-05-15 |
2020-11-19 |
Chemocentryx, Inc. |
Triaryl compounds for treatment of pd-l1 diseases
|
|
PE20221083A1
(es)
|
2019-06-17 |
2022-07-05 |
Deciphera Pharmaceuticals Llc |
Inhibidores de la autofagia de la amida aminopirimidina y sus metodos de uso
|
|
EP4013412B1
(en)
|
2019-08-12 |
2026-01-28 |
Deciphera Pharmaceuticals, LLC |
Ripretinib for treating gastrointestinal stromal tumors
|
|
TWI878335B
(zh)
|
2019-08-12 |
2025-04-01 |
美商迪賽孚爾製藥有限公司 |
治療胃腸道基質瘤方法
|
|
US20230277522A9
(en)
|
2019-08-12 |
2023-09-07 |
Deciphera Pharmaceuticals, Llc |
Methods for treating vascular malformations
|
|
JP7626910B2
(ja)
|
2019-10-24 |
2025-02-05 |
ピエール ファーブル メディカモン |
Ｒａｆキナーゼの阻害剤
|
|
JP7214925B2
(ja)
|
2019-12-06 |
2023-01-30 |
メッドシャイン ディスカバリー インコーポレイテッド |
Ｐａｎ－ＲＡＦキナーゼ阻害剤としてのビアリール化合物
|
|
EP4084779B1
(en)
|
2019-12-30 |
2024-10-09 |
Deciphera Pharmaceuticals, LLC |
Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluorophenyl)-3-phenylurea
|
|
MX2022008103A
(es)
|
2019-12-30 |
2022-09-19 |
Deciphera Pharmaceuticals Llc |
Formulaciones de inhibidores de la cinasa amorfa y metodos de estas.
|
|
CN115484948A
(zh)
|
2020-01-29 |
2022-12-16 |
福宏治疗公司 |
化合物及其用途
|
|
WO2021180238A1
(zh)
|
2020-03-13 |
2021-09-16 |
郑州同源康医药有限公司 |
一类用作激酶抑制剂的化合物及其应用
|
|
WO2022060996A1
(en)
|
2020-09-18 |
2022-03-24 |
Kinnate Biopharma Inc. |
Inhibitors of raf kinases
|
|
TW202229239A
(zh)
|
2020-09-23 |
2022-08-01 |
日商武田藥品工業股份有限公司 |
作為ｒｉｐｋ２抑制劑之３－（６－胺基吡啶－３－基）苯甲醯胺衍生物
|
|
WO2022081469A1
(en)
|
2020-10-12 |
2022-04-21 |
Kinnate Biopharma Inc. |
Inhibitors of raf kinases
|
|
CN117136062A
(zh)
|
2020-11-25 |
2023-11-28 |
德西费拉制药有限责任公司 |
Vps34抑制剂的抗病毒活性
|
|
CN117241829A
(zh)
|
2020-11-25 |
2023-12-15 |
德西费拉制药有限责任公司 |
Vps34抑制剂的抗病毒活性
|
|
CA3199999A1
(en)
|
2020-11-25 |
2022-06-02 |
Deciphera Pharmaceuticals, Llc |
Morpholino derivatives as vsp34 inhibitors for use in the treatment of a viral infection
|
|
US11801238B2
(en)
|
2020-11-25 |
2023-10-31 |
Deciphera Pharmaceuticals, Llc |
Anti-viral activity of VPS34 inhibitors
|
|
CN117241800A
(zh)
|
2020-11-25 |
2023-12-15 |
德西费拉制药有限责任公司 |
Vps34抑制剂的抗病毒活性
|
|
CA3200031A1
(en)
|
2020-11-25 |
2022-06-02 |
Deciphera Pharmaceuticals, Llc |
Anti-viral activity of vps34 inhibitors
|